Revista Espanola De Medicina Nuclear最新文献_第10页

Síndrome de discinesia apical transitoria (Tako-Tsubo) que simula un infarto agudo de miocardio [短暂性心尖功能障碍综合征(Tako-Tsubo)模拟急性心肌梗死]。

Revista Espanola De Medicina Nuclear Pub Date : 2011-03-01 DOI: 10.1016/j.remn.2010.03.009

M.J. Carrero Lérida , M.C. Mariscal Cerrato , C. Dávila Arias , A. López Ruiz , J. Caballero Güeto

引用次数: 9

Agenda 议程

Revista Espanola De Medicina Nuclear Pub Date : 2011-03-01 DOI: 10.1016/j.remn.2011.02.006

引用次数: 0

Identificación preoperatoria mediante SPECT/TAC de un ganglio centinela intramamario en una paciente con cáncer de mama. Significado y relevancia clínica 乳腺癌患者胸内前哨神经节的SPECT/CT术前鉴定。意义和临床意义

Revista Espanola De Medicina Nuclear Pub Date : 2011-03-01 DOI: 10.1016/j.remn.2010.09.008

A. Andrés, E. Prats, A. Santapau, L. Tardín, P. Razola, A. Parra, E.F. Rambalde, J. Banzo

引用次数: 6

EVIDENCIAS EN MEDICINA NUCLEAR. Selección de publicaciones, Enero-Junio 2010 核医学的证据。出版物选集，2010年1月至6月

Revista Espanola De Medicina Nuclear Pub Date : 2011-03-01 DOI: 10.1016/j.remn.2010.12.003

引用次数: 0

Uso de la PET-18F-FDG en pacientes con sospecha de recurrencia de cáncer diferenciado de tiroides por anticuerpos anti-tiroglobulina elevados y rastreo 131I negativo PET-18F-FDG在疑似甲状腺癌复发的抗甲状腺球蛋白抗体升高和筛查131I阴性患者中的应用

Revista Espanola De Medicina Nuclear Pub Date : 2011-03-01 DOI: 10.1016/j.remn.2010.10.012

S. Sanz Viedma , I. Borrego Dorado , J.R. Rodríguez Rodríguez , E. Navarro González , R. Vázquez Albertino , R. Fernández López , A. Agudo Martínez

{"title":"Uso de la PET-18F-FDG en pacientes con sospecha de recurrencia de cáncer diferenciado de tiroides por anticuerpos anti-tiroglobulina elevados y rastreo 131I negativo","authors":"S. Sanz Viedma , I. Borrego Dorado , J.R. Rodríguez Rodríguez , E. Navarro González , R. Vázquez Albertino , R. Fernández López , A. Agudo Martínez","doi":"10.1016/j.remn.2010.10.012","DOIUrl":"10.1016/j.remn.2010.10.012","url":null,"abstract":"<div><h3>Aim</h3><p>To evaluate the utility of <sup>18F</sup>FDG-PET for patients diagnosed of differentiated thyroid carcinoma who present risk of disease and invaluable levels of thyroglobulin (Tg) by the presence of antibodies antithyroglobulin (AbTg).</p></div><div><h3>Material and methods</h3><p>Retrospective study of 7 women of 40 years old and histological diagnosis of differentiated thyroid cancer (7 papillary tumours) that were sent to our department for the accomplishment of<sup>18F</sup>FDG-PET study because of suspicion of disease, due to <sup>131</sup>I negative and high levels of AbTg, between the year 2002 and 2007. 11 PET scans were obtained after the intravenous injection of 370-434 MBq of <sup>18F</sup>FDG in normoglycemia conditions and previous administration of muscle relaxant, hydration and diuretic. The results of <sup>18F</sup>FDG-PET scans were confirmed by pathologic examination or clinical outcome and radiographic examination for more than 24 months.</p></div><div><h3>Results</h3><p>The prevalence of recurrence in our population was 57.14%. All patients presented levels of Tg lower than 3 ng/dl and AbTg superior to 200 UI/ml. Three patients had precedent thyroiditis. Out of 11 scans performed 3 of them were negative and 8 cases were found positive. It ruled out the existence of disease in three patients and localized the presence of recurrence in 4 patients.</p></div><div><h3>Conclusion</h3><p><sup>18F</sup>FDG-PET</p><p>CONCLUSION: 18F-FDG-PET is a useful diagnostic tool for the detection of recurrence as well as to rule out the existence of disease with a high accuracy, in patients with differentiated thyroid carcinoma with <sup>131</sup>I whole body scan negative but with pathological elevation of antithyroglobulin antibodies.</p></div>","PeriodicalId":54464,"journal":{"name":"Revista Espanola De Medicina Nuclear","volume":"30 2","pages":"Pages 77-82"},"PeriodicalIF":0.0,"publicationDate":"2011-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.remn.2010.10.012","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29684157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 6

Surveillance of radiopharmaceuticals in Latin American: an alert 拉丁美洲放射性药物监测:警报

Revista Espanola De Medicina Nuclear Pub Date : 2011-03-01 DOI: 10.1016/j.remn.2010.10.010

R. Santos-Oliveira , S. Weiss Smith , M. de Souza Albernaz , J. Augusto Bordim , L. Jorge Antunes

引用次数: 3

Noticias 新闻

Revista Espanola De Medicina Nuclear Pub Date : 2011-03-01 DOI: 10.1016/j.remn.2011.02.007

引用次数: 0

Valor pronóstico de la gammagrafía de perfusión miocárdica con 201Tl normal en el postinfarto agudo de miocardio 201TL正常心肌灌注显像对急性心肌梗塞后的预后价值

Revista Espanola De Medicina Nuclear Pub Date : 2011-03-01 DOI: 10.1016/j.remn.2010.09.006

F.G. Gallardo , M.V. Gómez , I. Terol

{"title":"Valor pronóstico de la gammagrafía de perfusión miocárdica con 201Tl normal en el postinfarto agudo de miocardio","authors":"F.G. Gallardo , M.V. Gómez , I. Terol","doi":"10.1016/j.remn.2010.09.006","DOIUrl":"https://doi.org/10.1016/j.remn.2010.09.006","url":null,"abstract":"<div><h3>Objective</h3><p>The purpose of this work has been to determine the prognostic value of normal thallium-201 myocardial perfusion scintigraphy (MPS) in patients who had suffered myocardial infarction in the three months prior to the examination.</p></div><div><h3>Material and methods</h3><p>A stress test followed by <sup>201</sup>Tl Gated SPECT was performed. A follow-up was made of 63 patients with normal perfusion scintigraphy. According to the MPS results, the patients were divided into 2 groups. Group I (n=63; 57% males, age 65±12), patients with normal MPS, and group II (n=60; 81% males, age 64±10), patients with abnormal MPS. The appearance of a new infarction or cardiac death occurring during this period (63±3 months) was analyzed. The appearance of events was related with the cardiovascular risk factors, perfusion study and ventricular function.</p></div><div><h3>Results</h3><p>Five events occurred in group I in 4 patients: 3 new infarctions and 2 cardiac deaths. In group II, there were 18 events in 14 patients: 8 new infarctions and 10 cardiac deaths (p<0,0001). The events were related with age, time from MPS, diabetes, size of perfusion defect and post stress ventricular ejection fraction. Mean survival en group I was 108 months (103–112) and in group II 97 (88–107) (p=0,01).</p></div><div><h3>Conclusion</h3><p>Patients with normal MPS had fewer major events than patients with abnormal MPS. The size of MPS has been related with the appearance of events. A depressed post-stress left ventricular ejection fraction has a poor prognosis.</p></div>","PeriodicalId":54464,"journal":{"name":"Revista Espanola De Medicina Nuclear","volume":"30 2","pages":"Pages 83-87"},"PeriodicalIF":0.0,"publicationDate":"2011-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.remn.2010.09.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72272726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

PET de doble fase con 18F-FDOPA como instrumento para la caracterización de tumores cerebrales 以18f -酞多巴为仪器的双相PET鉴定脑肿瘤

Revista Espanola De Medicina Nuclear Pub Date : 2011-03-01 DOI: 10.1016/j.remn.2010.11.007

M. González-Forero, E. Prieto, I. Domínguez, C. Vigil, I. Peñuelas, J. Arbizu

{"title":"PET de doble fase con 18F-FDOPA como instrumento para la caracterización de tumores cerebrales","authors":"M. González-Forero, E. Prieto, I. Domínguez, C. Vigil, I. Peñuelas, J. Arbizu","doi":"10.1016/j.remn.2010.11.007","DOIUrl":"10.1016/j.remn.2010.11.007","url":null,"abstract":"<div><p><sup>18</sup>F-FDOPA is an amino acid analogue used to evaluate presynaptic dopaminergic activity, which has aroused great interest in neuro-oncology. We have evaluated five <sup>18</sup>F-FDOPA PET studies of patients referred for study of parkinsonian syndrome. Two subjects had previously treated high-grade brain tumors, one nonspecific brain injury, and 2 subjects presented unexpected tumoral lesions. For all lesions SUVmax, time to SUVmax and tumor-to-normal grey matter SUVmax rate (T/N) were calculated, and 90minutes <sup>18</sup>F-FDOPA kinetics were analyzed. Tumor lesions corresponded to three malignant neurocytomas, one meningioma, one pineocytoma and one intrasinusal hemangioma. Both malignant and benign tumors exhibited high uptake of <sup>18</sup>F-FDOPA well above the normal cortex. However, the analysis of the curve uptake displayed characteristic patterns that facilitate the characterization of tumor lesions. A dual phase maximum uptake was observed, with an early 10minutes uptake in malignant lesions, and a late 60 to 90minutes uptake in benign or low grade lesions.</p></div>","PeriodicalId":54464,"journal":{"name":"Revista Espanola De Medicina Nuclear","volume":"30 2","pages":"Pages 88-93"},"PeriodicalIF":0.0,"publicationDate":"2011-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.remn.2010.11.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29684160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 12

PET-TAC con 18F-FDG tras llenado retrógrado vesical en el estudio de patología pélvica maligna 膀胱逆行填充后PET-TAC与18F-FDG在盆腔恶性病理研究中的应用

Revista Espanola De Medicina Nuclear Pub Date : 2011-03-01 DOI: 10.1016/j.remn.2010.10.013

A.M. García Vicente, A. Núñez García, A. Palomar Muñoz, J.P. Pilkington Woll, M.E. Bellón Guardia, B. González García, A. Soriano Castrejón

{"title":"PET-TAC con 18F-FDG tras llenado retrógrado vesical en el estudio de patología pélvica maligna","authors":"A.M. García Vicente, A. Núñez García, A. Palomar Muñoz, J.P. Pilkington Woll, M.E. Bellón Guardia, B. González García, A. Soriano Castrejón","doi":"10.1016/j.remn.2010.10.013","DOIUrl":"10.1016/j.remn.2010.10.013","url":null,"abstract":"<div><h3>Aim</h3><p>To assess the role of PET/CT with retrograde filling of urinary bladder (RFUB) in the assessment of pelvic malignancy in patients with urothelial or gynecological tumors.</p></div><div><h3>Material and methods</h3><p>A retrospective longitudinal analysis based on 62 studies belonging to 52 patients was performed. All of them had a history of pelvic malignancy (29 urothelial and 23 gynecological) and 42 had undergone previous treatments. All patients underwent a standard PET/CT protocol. Inclusion criteria were radiological alterations in pelvic organs or increased urinary activity of <sup>18</sup>F-FDG that hindered evaluation of the pelvic structures. Pathological pelvic locations were assessed as the additional value of PET/CT with RFUB. The pathologic lesions were histologically or clinically evaluated with a minimum follow-up of 12 months.</p></div><div><h3>Results</h3><p>Pelvic malignancy was confirmed in 33 cases, 16 of which were of urothelial origin. A total of 35/62 studies showed a pathologic PET/CT in pelvis, 4 of them were false positive and 2 false negative. In 19 cases, malignancy was detected in the bladder wall, 16 of which were true positive. No false negative was detected. Regarding standard imaging acquisition, RFUB helped to confirm or rule out bladder and/or gynecological disease in 54 cases.</p></div><div><h3>Conclusion</h3><p>Retrograde bladder filling is a highly recommended technique in the assessment of malignant pelvic disease, especially of bladder origin.</p></div>","PeriodicalId":54464,"journal":{"name":"Revista Espanola De Medicina Nuclear","volume":"30 2","pages":"Pages 71-76"},"PeriodicalIF":0.0,"publicationDate":"2011-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.remn.2010.10.013","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29684156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 6